Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: Comparison of reserpine-induced myalgia and chronic constriction injury rats

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 242-249

  Nagakura, Yukinori ^a   Takahashi, Masayasu ^a   Noto, Takahisa ^a   Sekizawa, Toshihiro ^a   Oe, Tomoya ^a   Yoshimi, Eiji ^a   Tamaki, Keisuke ^a   Shimizu, Yasuaki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Chronic pain; Fibromyalgia; Neuropathic pain; Reserpine induced myalgia; Sodium channel blocker; Substantia nigra

Indexed keywords

BIOGENIC AMINE; MEXILETINE; RESERPINE; SODIUM CHANNEL BLOCKING AGENT;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CHRONIC PAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; FIBROMYALGIA; HISTOPATHOLOGY; HYPERALGESIA; HYPERSENSITIVITY; MALE; MYALGIA; NERVE CELL; NERVOUS TISSUE; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD; SUBSTANTIA NIGRA;

ANIMALS; CHRONIC PAIN; CONSTRICTION; DISEASE MODELS, ANIMAL; FIBROMYALGIA; HYPERALGESIA; MALE; NEURALGIA; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RESERPINE; SCIATIC NERVE;

EID: 80053584077     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.023     Document Type: Article

References (45)

1. Arendt-Nielsen L., Sluka K.A., Nie H.L. Experimental muscle pain impairs descending inhibition. Pain 2008, 140:465-471.
2. Azkue J.J., Zimmermann M., Hsieh T.F., Herdegen T. Peripheral nerve insult induces NMDA receptor-mediated, delayed degeneration in spinal neurons. Eur J Neurosci 1998, 10:2204-2206.
3. Bak I.J. The ultrastructure of the substantia nigra and caudate nucleus of the mouse and the cellular localization of catecholamines. Exp Brain Res 1967, 3:40-57.
4. Basbaum A.I., Fields H.L. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978, 4:451-462.
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
6. Berrocoso E., Mico J.A., Vitton O., Ladure P., Newman-Tancredi A., Depoortère R., Bardin L. Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain. Eur J Pharmacol 2011, 655:46-51.
7. 2O) exposure leads to persistent alleviation of neuropathic pain in rats. J Pain 2010, 11:13-23.
8. Borsook D., Upadhyay J., Chudler E.H., Becerra L. A key role of the basal ganglia in pain and analgesia - insights gained through human functional imaging. Mol Pain 2010, 6:27.
9. Bradley L.A. Pathophysiology of fibromyalgia. Am J Med 2009, 122:S22-S30.
10. Cameron A.A., Cliffer K.D., Dougherty P.M., Garrison C.J., Willis W.D., Carlton S.M. Time course of degenerative and regenerative changes in the dorsal horn in a rat model of peripheral neuropathy. J Comp Neurol 1997, 379:428-442.
11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
12. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994, 59:369-376.
13. Chudler E.H., Dong W.K. The role of the basal ganglia in nociception and pain. Pain 1995, 60:3-38.
14. Clauw D.J. Fibromyalgia: an overview. Am J Med 2009, 122:S3-S13.
15. Cook D.B., Lange G., Ciccone D.S., Liu W.C., Steffener J., Natelson B.H. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004, 31:364-378.
16. Costa B., Trovato A.E., Comelli F., Giagnoni G., Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol 2007, 556:75-83.
17. Fritschy J.M., Frondoza C.G., Grzanna R. Differential effects of reserpine on brainstem catecholaminergic neurons revealed by Fos protein immunohistochemistry. Brain Res 1991, 562:48-56.
18. Gradl G., Gaida S., Gierer P., Mittlmeier T., Vollmar B. In vivo evidence for apoptosis, but not inflammation in the hindlimb muscle of neuropathic rats. Pain 2004, 112:121-130.
19. Griep E.N., Boersma J.W., Lentjes E.G., Prins A.P., van der Korst J.K., de Kloet E.R. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 1998, 25:1374-1381.
20. Guilbaud G., Gautron M., Jazat F., Ratinahirana H., Hassig R., Hauw J.J. Time course of degeneration and regeneration of myelinated nerve fibres following chronic loose ligatures of the rat sciatic nerve: can nerve lesions be linked to the abnormal pain-related behaviours?. Pain 1993, 53:147-158.
21. Hama A.T., Borsook D. Behavioral and pharmacological characterization of a distal peripheral nerve injury in the rat. Pharmacol Biochem Behav 2005, 81:170-181.
22. Hu B., Doods H., Treede R.D., Ceci A. Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833. Pain 2009, 143:206-212.
23. Myers R.R., Yamamoto T., Yaksh T.L., Powell H.C. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia. Anesthesiology 1993, 78:308-316.
24. Nagakura Y., Oe T., Aoki T., Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 2009, 146:26-33.
25. Nakamura S., Atsuta Y. Effect of sodium channel blocker (mexiletine) on pathological ectopic firing pattern in a rat chronic constriction nerve injury model. J Orthop Sci 2005, 10:315-320.
26. Nakazato-Imasato E., Tanimoto-Mori S., Kurebayashi Y. Effect of mexiletine on dynamic allodynia induced by chronic constriction injury of the sciatic nerve in rats. J Vet Med Sci 2009, 71:991-994.
27. Oe T., Tsukamoto M., Nagakura Y. Reserpine causes biphasic nociceptive sensitivity alteration in conjunction with brain biogenic amine tones in rats. Neuroscience 2010, 169:1860-1871.
28. Paulson P.E., Casey K.L., Morrow T.J. Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat. Pain 2002, 95:31-40.
29. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006, 80:53-83.
30. Potvin S., Grignon S., Marchand S. Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 2009, 63:390-402.
31. Pozos R.S., Holbrook J.R. Tremorogenisis: effects of reserpine on the substantia nigra. Exp Neurol 1971, 32:317-330.
32. Pradhan A.A., Yu X.H., Laird J.M. Modality of hyperalgesia tested, not type of nerve damage, predicts pharmacological sensitivity in rat models of neuropathic pain. Eur J Pain 2010, 14:503-509.
33. Reddy S.V., Yaksh T.L. Spinal noradrenergic terminal system mediates antinociception. Brain Res 1980, 189:391-401.
34. Russell I.J., Vaeroy H., Javors M., Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992, 35:550-556.
35. Sarzi-Puttini P., Atzeni F., Cazzola M. Neuroendocrine therapy of fibromyalgia syndrome: an update. Ann N Y Acad Sci 2010, 1193:91-97.
36. Schäfers M., Sorkin L.S., Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 2003, 104:579-588.
37. Schmidt-Wilcke T., Clauw D.J. Pharmacotherapy in fibromyalgia (FM) - implications for the underlying pathophysiology. Pharmacol Ther 2010, 127:283-294.
38. Sluka K.A., Price M.P., Breese N.M., Stucky C.L., Wemmie J.A., Welsh M.J. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 2003, 106:229-239.
39. Staud R. Pharmacological treatment of fibromyalgia syndrome: new developments. Drugs 2010, 70:1-14.
40. Sugimoto T., Bennett G.J., Kajander K.C. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine. Pain 1990, 42:205-213.
41. Tremont-Lukats I.W., Challapalli V., McNicol E.D., Lau J., Carr D.B. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005, 101:1738-1749.
42. Wei F., Guo W., Zou S., Ren K., Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 2008, 28:10482-10495.
43. Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19-28.
44. Wood P.B. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008, 8:781-797.
45. Wood P.B., Schweinhardt P., Jaeger E., Dagher A., Hakyemez H., Rabiner E.A., Bushnell M.C., Chizh B.A. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 2007, 25:3576-3582.